Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 22: 1256-1261, 1976;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hino, M
Right arrow Articles by Oya, H
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hino, M
Right arrow Articles by Oya, H

Clinical Chemistry, Vol 22, 1256-1261, Copyright © 1976 by American Association for Clinical Chemistry

X-Prolyl dipeptidyl-aminopeptidase activity, with X-proline p- nitroanilides as substrates, in normal and pathological human sera

M Hino, H Fuyamada, T Hayakawa, T Nagatsu and H Oya

X-Prolyl dipeptidyl-aminopeptidase (no EC no. assigned) activity in normal and pathological human sera was assayed with several newly synthesized X-proline p-nitroanilides as chromogenic substrates. Normal values for 88 healthy subjects (15 to 81 years old), with glycylproline p-nitroanilide as substrate at pH 8.7, were 54.9 +/- 1.5 (SE) (range, 25.7 - 96.0) mumol/min per liter of serum at 37 degrees C. The results suggest that the enzyme activities with all X-proline p-nitroanilides were increased in patients with hepatitis and decreased in patients with gastric cancer. On Sephadex G-200 column chromatography, normal human sera showed a single peak of enzyme activity with glycylproline p- nitroanilide as the substrate, which coincided with the peak with glycylproline beta-naphthylamide but was different from the peaks with leucine beta-naphthylamide. Sera from patients with hepatitis or liver cirrhosis showed an increase in the normal peak and the appearance of another new peak with glycylproline p-nitroanilide as substrate.


The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Physiol. Renal Physiol.Home page
A. C. C. Girardi, L. E. Fukuda, L. V. Rossoni, G. Malnic, and N. A. Reboucas
Dipeptidyl peptidase IV inhibition downregulates Na+-H+ exchanger NHE3 in rat renal proximal tubule
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F414 - F422.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. S.P. Lam, J. C. Burnett Jr, L. Costello-Boerrigter, R. J. Rodeheffer, and M. M. Redfield
Alternate Circulating Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide Forms in the General Population
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1193 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. C. C. Girardi, F. Knauf, H.-U. Demuth, and P. S. Aronson
Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells
Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1238 - C1245.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. P. Goetze
Biochemistry of Pro-B-Type Natriuretic Peptide-Derived Peptides: The Endocrine Heart Revisited
Clin. Chem., September 1, 2004; 50(9): 1503 - 1510.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. C. C. Girardi, B. C. Degray, T. Nagy, D. Biemesderfer, and P. S. Aronson
Association of Na+-H+ Exchanger Isoform NHE3 and Dipeptidyl Peptidase IV in the Renal Proximal Tubule
J. Biol. Chem., November 30, 2001; 276(49): 46671 - 46677.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. S. Duke-Cohan, C. Morimoto, J. A. Rocker, and S. F. Schlossman
A Novel Form of Dipeptidylpeptidase IV Found in Human Serum
J. Biol. Chem., June 9, 1995; 270(23): 14107 - 14114.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by the American Association for Clinical Chemistry.